CCG
MDT icon

Cypress Capital Group’s Medtronic MDT Stock Holding History

Cypress Capital Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$465K Buy
5,365
+66
+1% +$6.32K 0.05% 179
2025
Q4 		$509K Buy
5,299
+456
+9% +$44.3K 0.06% 161
2025
Q3 		$461K Buy
4,843
+342
+8% +$31.4K 0.06% 167
2025
Q2 		$392K Buy
4,501
+593
+15% +$50.3K 0.05% 170
2025
Q1 		$351K Sell
3,908
-2,966
-43% -$265K 0.05% 166
2024
Q4 		$549K Sell
6,874
-5,599
-45% -$485K 0.07% 173
2024
Q3 		$1.12M Buy
12,473
+2,798
+29% +$235K 0.13% 129
2024
Q2 		$762K Sell
9,675
-34
-0.4% -$2.79K 0.09% 168
2024
Q1 		$846K Sell
9,709
-14
-0.1% -$1.2K 0.1% 169
2023
Q4 		$801K Buy
9,723
+814
+9% +$62K 0.1% 168
2023
Q3 		$698K Buy
8,909
+593
+7% +$49.6K 0.1% 179
2023
Q2 		$733K Buy
8,316
+594
+8% +$51.1K 0.11% 184
2023
Q1 		$623K Buy
+7,722
New +$629K 0.1% 194
2022
Q3 		– Sell
-4,099
Closed -$368K – 287
2022
Q2 		$368K Sell
4,099
-260
-6% -$26.3K 0.06% 226
2022
Q1 		$484K Buy
4,359
+468
+12% +$49.4K 0.06% 219
2021
Q4 		$403K Buy
3,891
+366
+10% +$42.4K 0.05% 228
2021
Q3 		$442K Hold
3,525
– – 0.06% 219
2021
Q2 		$438K Sell
3,525
-98
-3% -$12.3K 0.06% 220
2021
Q1 		$428K Sell
3,623
-1,576
-30% -$185K 0.06% 220
2020
Q4 		$609K Buy
5,199
+1,030
+25% +$113K 0.09% 182
2020
Q3 		$433K Sell
4,169
-714
-15% -$71.7K 0.07% 190
2020
Q2 		$448K Buy
4,883
+1,325
+37% +$127K 0.08% 180
2020
Q1 		$320K Buy
3,558
+153
+4% +$16.3K 0.07% 159
2019
Q4 		$387K Buy
3,405
+232
+7% +$25.5K 0.07% 179
2019
Q3 		$345K Buy
+3,173
New +$331K 0.07% 192
2018
Q1 		– Sell
-2,885
Closed -$233K – 219
2017
Q4 		$233K Buy
+2,885
New +$231K 0.05% 198
2016
Q4 		– Sell
-2,500
Closed -$216K – 190
2016
Q3 		$216K Sell
2,500
-525
-17% -$45.7K 0.05% 173
2016
Q2 		$263K Buy
+3,025
New +$245K 0.06% 154
2016
Q1 		– Sell
-3,764
Closed -$290K – 175
2015
Q4 		$290K Buy
+3,764
New +$283K 0.07% 165
2015
Q3 		– Sell
-4,347
Closed -$322K – 199
2015
Q2 		$322K Hold
4,347
– – 0.07% 168
2015
Q1 		$339K Buy
4,347
+199
+5% +$15.1K 0.08% 171
2014
Q4 		$299K Sell
4,148
-698
-14% -$48.5K 0.07% 189
2014
Q3 		$301K Sell
4,846
-4,639
-49% -$295K 0.07% 175
2014
Q2 		$605K Buy
9,485
+5,485
+137% +$333K 0.14% 122
2014
Q1 		$246K Hold
4,000
– – 0.06% 189
2013
Q4 		$230K Hold
4,000
– – 0.06% 194
2013
Q3 		$213K Sell
4,000
-175
-4% -$9.42K 0.05% 195
2013
Q2 		$215K Buy
+4,175
New +$206K 0.04% 203

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cypress Capital Group's MDT Position: Q1 2026 in Review

Cypress Capital Group increased its Medtronic (MDT) stake by 1.2% in Q1 2026, buying an estimated $6.32K and bringing the position to 5,365 shares worth $465K. The position accounts for 0.05% of the portfolio, ranked #179.

Cypress Capital Group first reported a position in MDT in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.12M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Cypress Capital Group held 5,365 shares of Medtronic worth $465K as of Q1 2026.
  • Cypress Capital Group bought 66 Medtronic shares in Q1 2026, an estimated $6.32K.
  • Medtronic made up 0.05% of Cypress Capital Group's portfolio in Q1 2026, its #179 holding.
  • Cypress Capital Group first reported a position in Medtronic in Q2 2013 and has held it in 38 quarters since.
  • Cypress Capital Group's Medtronic position peaked at $1.12M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Cypress Capital Group's 13F filing for Q1 2026, filed 15 May 2026.